Company Profiles

driven by the PitchBook Platform


Out of Business LATEST DEAL TYPE

Provider of biomaterials-based products designed to treat the early-stage degeneration of the spine. The company's biomaterials-based product, DiscCell, is an injectable, in-situ setting, radio-opaque, non-hydrogel polymer material that augments or replaces the diseased nucleus pulposus of the spinal disc, enabling patients to prevent a recurrence of back or leg pain at the treatment site.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
400 East Lancaster Avenue
Suite 300
Wayne, PA 19087
United States

+1 (610) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Gentis’s full profile, request a free trial.

Gentis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Jun-2016 000.00 Completed Out of Business
5. Later Stage VC 02-Feb-2014 00000 000.00 Completed Profitable
4. Later Stage VC 00000 0000 Completed Profitable
3. Secondary Transaction - Private 000.00 Completed Profitable
2. Later Stage VC (Series B) 19-Jul-2010 $548K $12.5M Completed Profitable
1. Later Stage VC (Series A) 22-Jun-2007 $12M $12M Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

Gentis Executive Team (4)

Name Title Board
Denis Grigorev Chief Executive Officer
Noel Rolon Vice President, Clinical & Regulatory Affairs
Paul Ducheyne Co-Founder, Chairman & Surgical Advisor

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Gentis Board Members (8)

Name Representing Role Since Contact
Paul Ducheyne Gentis Co-Founder, Chairman & Surgical Advisor 000 0000

7 Former Board Members

You’re viewing 1 of 8 board members. Get the full list »
Questions or concerns about this profile? Reach out to